HDSA’s annual Research Year in Review webinar is now available to view. Check it out for an overview of HDSA’s research activities over the past year, how the research landscape has changed over the course of the past decade, and how we are planning for a future that includes HD therapies.  


The 2020 HD Research Pipeline 

Research into new therapies for Huntington’s disease is a dynamic process, and there are more than 20 ongoing or soon-to-begin clinical trials of drugs for HD. Check out HDSA’s webpage discussing the HD research pipeline which includes drugs in development and clinical trials happening all over the world. To read about and match to trials that are recruiting participants, go to www.hdtrialfinder.org today!  


Using AI to Map the HD Brain 

This week, researchers at IBM and the HD research foundation CHDI published collaborative work exploring new brain mapping techniques that could potentially provide more information about HD progression from a single fMRI scan. An IBM blog post discusses their results in detail, in plain language. The researchers used data from participants in the TRACK-HD study who performed cognitive tests and had their brains scanned multiple times over several years. They applied artificial intelligence (AI) techniques to these images and cognitive data and found that brain scans could be much more informative about stage and progression of HD than previously thought. In the future, this could help individuals and families with HD to make decisions about their lives and treatment strategies, or to determine whether a person is a good fit for a new clinical trial.